Rehabilitation Centre in India
Struggling with addiction in Pune? Trucare Trust...
PreciseDx Secures $20.7M to Improve Diagnostics in Oncology Using AI Technology
PreciseDx Secures $20.7M to Improve Diagnostics in Oncology Using AI TechnologyPreciseDx, a pioneering medical technology leveraging the power of artificial intelligence (AI) to improve diagnostics in oncology, has secured $20.7 million in a series B funding round to accelerate growth and expansion. Co-founded in 2020 by Jack Zeineh MD, and Gerardo Fernandez MD, the company’s latest financing round was spearheaded by Eventide Asset Management, supported by contributions from Quest Diagnostics, GenHenn Capital Venture, Labcorp, and existing investors. The new capital brings PreciseDx’s total funding to $31.5 million since its launch.
Please login to comment on this Post